BofA downgraded Ardent Health (ARDT) to Underperform from Neutral with a $146 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARDT:
- Buy Rating for Ardent Health Partners, Inc. Amid Strong Sector Trends and Discounted Valuation
- Ardent Health Announces Departure of Hospital Operations President
- Ardent Health Partners, Inc.: Strategic Growth and Stable Outlook Justify Buy Rating
- RBC a buyer of hospital stocks on White House memo selloff
- Ardent Health falls -7.3%